Health
-
Trans people with Long COVID navigate a new “dark age” in trans health
We spoke with and surveyed dozens of trans people navigating gender-affirming care and Long COVID during Trump’s second term.
-
I interviewed five people with Long COVID in prison. They are invisible in the system.
While there are no data sources on Long COVID in prison, experts suspect rates of the disease may be higher there than in the general population. They face high reinfection risks and poor access to medical care.
-
COVID-19 — not TikTok — is disabling young women
The Telegraph published an article titled, “How having a disability became cool.” This article shores up the government narrative that rising rates of disability are being driven, not by the ongoing and unchecked spread of COVID-19, but by people just deciding they want to “identify as disabled.”
-
We made a COVID-19 memorial in the ashes of a Joshua tree forest
Despite nearly 1.3 million deaths and counting, there is still not a national memorial for the pandemic. Our informal memorial in the middle of the Mojave Desert is one small way to remember those we’ve lost so far.
-
Breast cancer exposed the lack of care I receive for Long COVID
Cancer has a sadly well-worn path. It showed me that I deserve dignity and support for Long COVID.
-
VIPER aims to fast track Long COVID biomarkers. Here’s how it works.
Led by researchers at UCSF, the research program plans to validate promising candidates for noninvasive tests that can be used to advance clinical trials.
-
How do you spot Long COVID misinformation?
In this episode, Miles Griffis and Betsy Ladyzhets talk to Long COVID physician, patient and advocate Zeest Khan about her Long COVID journey, how she looks at new research and off-label treatments as a physician, and how to spot misinformation and pseudoscience online.
-
Dysautonomia conference centers biomarkers and post-exertional malaise
The 14th annual Dysautonomia International conference outside Houston included presentations on the role of autoimmunity in dysautonomia and a biobank initiative for POTS research.
-
Experimental peptides are being advertised for Long COVID. But the evidence is trailing behind.
Some FDA-approved GLP-1s are being studied in clinical trials for the disease, but their results aren’t available yet. Experts caution against using experimental peptides for Long COVID.
-
Stop telling women their Long COVID is menopause
From friends to medics, women are used to having their health issues dismissed, minimized, or blamed on their hormones.
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
Trans people with Long COVID navigate a new “dark age” in trans health
-
National COVID-19 trends, October 13
-
Research updates, October 13
-
How I built a COVID-safer school that’s become the heart of a more caring community
-
Biological pathways and mechanistic trials centered at new Long COVID conference in Amsterdam
Tags
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance